Latest News - Atopic Dermatitis

Thursday, November 16, 2017 |,, Research and Publications

Water Baths As Effective As Bleach Baths for Eczema

Water baths are as good as bleach baths for treating eczema, and they are safer, finds a new Northwestern Medicine study. Bleach baths can cause stinging and burning of skin, and occasionally even …

Read the full story

Thursday, November 16, 2017 |,,,, Research and Publications

Parent-supplied Photos May Allow Pediatric Derms to Make Virtual Diagnoses

Parent-supplied photos taken via smartphone cameras can allow pediatric dermatologists to make a diagnosis without an office visit in many cases, new research shows. This finding, which appear…

Read the full story

Tuesday, November 14, 2017 | Personnel/Company News,,,,, Valeant NJ

Ortho Dermatologics Announces Aspire Higher Scholarship Honorees

Ortho Dermatologics announced the nine recipients of the Aspire Higher Scholarship program, which honors the achievements of applicants or current attendees of an accredited, nonprofit, two- or four-y…

Read the full story

Monday, November 13, 2017 | Personnel/Company News,,, Johnson & Johnson

Calling all Innovators: J & J Launches Digital Beauty QuickFire Challenge

Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., is launching the Digital Beauty QuickFire Challenge. The challenge will encourage start-up companies…

Read the full story

Wednesday, November 08, 2017 |, Research and Publications

Possible Eczema Breakthrough? S. aureus May Promote Skin Inflammation via IL-36-Mediated T Cell Responses

Toxin-producing bacteria on the surface of our skin may induce a protein that causes our own cells to react and cause inflammation, according to research published online in Cell Host & Microbe. …

Read the full story

Monday, October 09, 2017 | Personnel/Company News,, Product Launches and Updates, Avene

Eau Thermale Avène Expands its #AveneHope Program

In recognition of Eczema Awareness Month and National Bullying Prevention Awareness Month this October, Eau Thermale Avène is expanding its #AveneHope program…

Read the full story

Monday, October 02, 2017 |, Research and Publications

Study IDs Racial and Ethnic Disparities in Pediatric Eczema Treatment

White children in the US are more likely to see a doctor for treatment of eczema than black children, despite the fact that the disease is likely more severe among minorities. Research from the Per…

Read the full story

Monday, September 18, 2017 |, Research and Publications

U.K Survey Reveals Eczema Treatment Knowledge Gap

Two thirds of UK eczema patients don’t understand that bacteria play a crucial role in their condition despite studies showing that Staphylococcus aureus is present on the skin in of more than 7…

Read the full story

Monday, September 18, 2017 |, Regeneron, Sanofi

EADV News: Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe AD

Dupixent with topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearing, itching, and patient reported quality of life measure in adults with moderate-to…

Read the full story

Thursday, September 14, 2017 |, Research and Publications, JAK inhibitors

Lilly’s Baricitinib Performs Well in Phase 2 AD Study

Lilly’s experimental JAK inhibitor Baricitinib in combination with a mid-potency topical corticosteroid (TCS) significantly improved the signs and symptoms of moderate-to-severe atopic dermatiti…

Read the full story

Wednesday, September 13, 2017 |, Product Launches and Updates, Research and Publications

Vanda's Tradipitant Improves Itch and Disease Severity in AD Patients

Vanda Pharmaceuticals Inc.’s tradipitant improved the intensity of the worst itch patients experienced, as well as atopic dermatitis (AD) disease severity,  according to results from an eig…

Read the full story

Monday, September 11, 2017 | Phase 3/4 Trials,,, Research and Publications

Lilly to Present New Data for Olumiant® and Taltz® at EADV

Eli Lilly and Company will present Phase 2 safety and efficacy data evaluating Olumiant® (baricitinib) for the treatment of moderate-to-severe atopic dermatitis (Lilly and Incyte Corporation …

Read the full story

Wednesday, September 06, 2017 | Personnel/Company News,, Research and Publications, Atopic Derm, Atopic Dermatitis

AD Breakthrough? Medimetriks’ MM36 Achieves Rapid Itch Relief, Safety in Phase 2 Study

Medimetriks’ PDE4 inhibitor, MM36, appears to be safe, well-tolerated and provides rapid itch relief when applied twice daily to pediatric and adolescent atopic dermatitis (AD) patients, accordi…

Read the full story

Thursday, August 31, 2017 | FDA Approval/Clearance, Healthcare Trends, Phase 3/4 Trials,,, Product Launches and Updates, Research and Publications

GBI Research: Global Dermatology Pipeline Will See Shift Toward Increased Use of Biologics

The global dermatology pipeline, which currently comprises 850 products with a disclosed stage of development, is primarily made up of drugs at an early stage of development, with the late stages of t…

Read the full story

Tuesday, August 15, 2017 |,, PuraCap

PuraCap Pharmaceuticals Introduces EpiCeram Quad Pack

PuraCap® Pharmaceutical is introducing the EpiCeram® Controlled Release Skin Barrier Emulsion Quad Pack, which contains four 100-gram airless pumps. EpiCeram® is a US Food and Drug Admi…

Read the full story
Load More